Two Sigma Advisers’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q1 | – | Sell |
-9,389
| Closed | -$97K | – | 2964 |
|
2021
Q4 | $97K | Buy |
9,389
+3,925
| +72% | +$40.6K | ﹤0.01% | 2414 |
|
2021
Q3 | $177K | Buy |
5,464
+1,935
| +55% | +$62.7K | ﹤0.01% | 2269 |
|
2021
Q2 | $151K | Buy |
3,529
+1,333
| +61% | +$57K | ﹤0.01% | 2307 |
|
2021
Q1 | $108K | Buy |
+2,196
| New | +$108K | ﹤0.01% | 2436 |
|
2016
Q2 | – | Sell |
-32
| Closed | -$39K | – | 2228 |
|
2016
Q1 | $39K | Hold |
32
| – | – | ﹤0.01% | 1997 |
|
2015
Q4 | $41K | Sell |
32
-2
| -6% | -$2.56K | ﹤0.01% | 1827 |
|
2015
Q3 | $52K | Sell |
34
-5
| -13% | -$7.65K | ﹤0.01% | 1761 |
|
2015
Q2 | $86K | Buy |
39
+23
| +144% | +$50.7K | ﹤0.01% | 1817 |
|
2015
Q1 | $47K | Sell |
16
-4
| -20% | -$11.8K | ﹤0.01% | 1822 |
|
2014
Q4 | $66K | Sell |
20
-3
| -13% | -$9.9K | ﹤0.01% | 2037 |
|
2014
Q3 | $79K | Buy |
23
+8
| +53% | +$27.5K | ﹤0.01% | 1695 |
|
2014
Q2 | $57K | Buy |
+15
| New | +$57K | ﹤0.01% | 1855 |
|
2014
Q1 | – | Sell |
-5
| Closed | -$17K | – | 2021 |
|
2013
Q4 | $17K | Buy |
+5
| New | +$17K | ﹤0.01% | 1749 |
|